Start Date
September 30, 2000
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Efavirenz
Oral Solution, Oral 200 - 600 mg (weight based), once daily. Until further treatment with Sustiva Oral Solution is not warranted.
Office Of John Montana, New York
St Luke'S-Roosevelt Hospital Center, New York
Women And Childrens Care Center, New York
Harlem Hospital Center, New York
Bronx Municipal Hospital Center, The Bronx
Montefiore Medical Center/Aecom, The Bronx
New York Medical College, Valhalla
Schneider'S Childrens Hospital, New Hyde Park
State University Of New York At Stony Brook, Stony Brook
Suny Upstate Medical University, Syracuse
Local Institution, Washington D.C.
Arnold Palmer Hospital For Children And Woman, Orlando
Children'S Diagnostic Treatment Center, Fort Lauderdale
Cleveland Clinic Florida, Weston
St Jude Children'S Research Hospital, Memphis
Metro Health Medical Center, Cleveland
Local Institution, Youngstown
The Children'S Memorial Hospital, Chicago
University Of Chicago, Chicago
Lsu Health Sciences Center, New Orleans
Local Institution, Houston
Local Institution, Phoenix
The Wellness Center, Las Vegas
Lac & Usc Medical Center, Los Angeles
Children'S Hospital, Boston
University Of Massachusetts Medical School, Worcester
Umdnj - New Jersey Medical School, Newark
Local Institution, Arecibo
Local Institution, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY